This webinar will focus on the recommendations for the 2024-25 virus season and implications of respiratory viruses on adults living with chronic medical conditions like asthma, COPD, diabetes and ...
VTAMA ® (tapinarof) cream, 1%, is a novel nonbiologic, non-steroidal topical therapy approved by the U.S. Food and Drug Administration (FDA) for treatment of mild, moderate, and severe plaque ...
LEO Pharma Inc., a global leader in medical dermatology, will present a comprehensive catalog of new data around investigational delgocitinib cream in the treatment of adults with moderate to severe ...